Galecto Biotech (private company)

galecto.com Follow

See something wrong or missing? Let us know

Offices:

Copenhagen

Category:

Biotech Health services

Business model:

B2B

Investors:

we tracked 2 investors

You need an account to access this feature. Login or create one from here. (it takes 20 seconds)

Total investments received (USD) - we tracked 3 transactions

You need an account to access this feature. Login or create one from here. (it takes 20 seconds)

M&A and Exit deals (USD) - we tracked 1 transaction

You need an account to access this feature. Login or create one from here. (it takes 20 seconds)

Galecto Biotech AB develops galectin modulators for the treatment of severe diseases, including fibrosis, cancer and inflammation

Companies with similar profile to Galecto Biotech:

Company	Criteria
NMD Pharma 66%	Similar verticals: Biotech, Health services Similar business models: B2B At least one vc investor: Novo Seeds Total raised in a similar range: 10M+ USD Minim one investor from outside Scandinavia: Yes
STipe Therapeutics 66%	Similar verticals: Biotech, Health services Similar business models: B2B At least one vc investor: Sunstone Life Science Ventures Total raised in a similar range: 10M+ USD Minim one investor from outside Scandinavia: Yes
AFYX Therapeutics 66%	Similar verticals: Biotech, Health services Similar business models: B2B At least one vc investor: Novo Seeds Total raised in a similar range: 10M+ USD Minim one investor from outside Scandinavia: Yes
Draupnir Bio 66%	Similar verticals: Biotech, Health services Similar business models: B2B At least one vc investor: Novo Seeds Total raised in a similar range: 10M+ USD Minim one investor from outside Scandinavia: Yes
Forendo Pharma 65%	Similar verticals: Health services Similar business models: B2B At least one vc investor: Novo Seeds, Sunstone Life Science Ventures At least one other investor: Merck Ventures Total raised in a similar range: 10M+ USD Minim one investor from outside Scandinavia: Yes
Sanifit Therapeutics 64%	Similar verticals: Biotech, Health services Similar business models: B2B At least one other investor: Ysios Capital Total raised in a similar range: 10M+ USD Minim one investor from outside Scandinavia: Yes
MinervaX 56%	Similar verticals: Biotech, Health services Similar business models: B2B At least one vc investor: Novo Seeds, Sunstone Life Science Ventures, Seed Capital Total raised in a similar range: 10M+ USD
AMRA 55%	Similar verticals: Health services Similar business models: B2B At least one vc investor: Novo Seeds Total raised in a similar range: 10M+ USD Minim one investor from outside Scandinavia: Yes
OxThera 55%	Similar verticals: Biotech Similar business models: B2B At least one vc investor: Sunstone Life Science Ventures Total raised in a similar range: 10M+ USD Minim one investor from outside Scandinavia: Yes
Acarix 55%	Similar verticals: Health services Similar business models: B2B At least one vc investor: Seventure Partners, Sunstone Life Science Ventures, Seed Capital Total raised in a similar range: 10M+ USD Minim one investor from outside Scandinavia: Yes
Orphazyme 55%	Similar verticals: Biotech Similar business models: B2B At least one vc investor: Sunstone Life Science Ventures Total raised in a similar range: 10M+ USD Minim one investor from outside Scandinavia: Yes
Aprea Therapeutics 54%	Similar verticals: Biotech, Health services Similar business models: B2B Total raised in a similar range: 10M+ USD Minim one investor from outside Scandinavia: Yes
Alvotech 54%	Similar verticals: Biotech, Health services Similar business models: B2B Total raised in a similar range: 10M+ USD Minim one investor from outside Scandinavia: Yes
Mobidiag 54%	Similar verticals: Biotech, Health services Similar business models: B2B Total raised in a similar range: 10M+ USD Minim one investor from outside Scandinavia: Yes
Unibio 54%	Similar verticals: Biotech, Health services Similar business models: B2B Total raised in a similar range: 10M+ USD Minim one investor from outside Scandinavia: Yes
ITBMed 54%	Similar verticals: Biotech, Health services Similar business models: B2B Total raised in a similar range: 10M+ USD Minim one investor from outside Scandinavia: Yes
Oncoinvent 54%	Similar verticals: Biotech, Health services Similar business models: B2B Total raised in a similar range: 10M+ USD Minim one investor from outside Scandinavia: Yes
Anaconda Biomed 53%	Similar verticals: Health services Similar business models: B2B At least one other investor: Ysios Capital Total raised in a similar range: 10M+ USD Minim one investor from outside Scandinavia: Yes
Merozyne Therapeutics 46%	Similar verticals: Biotech, Health services Similar business models: B2B At least one vc investor: Novo Seeds
Antag 46%	Similar verticals: Biotech, Health services Similar business models: B2B At least one vc investor: Novo Seeds